Table 1 Demographic and clinical characteristics of the 24 children and adolescents with TS
Sodium valproate (n = 12) | Aripiprazole (n = 12) | χ2/t/Z | p | |
|---|---|---|---|---|
Sex | 0.000 | > 0.999 | ||
Male | 10 | 10 | ||
Female | 2 | 2 | ||
Age | 9.75 ± 3.42 | 10.17 ± 3.43 | 0.298 | 0.768 |
Weight | 34.75 ± 9.88 | 34.67 ± 7.79 | 0.023 | 0.982 |
Duration of tic disorders | 3.00 (2.00, 3.38) | 2.75 (2.00, 3.78) | 0.060 | 0.977 |
IQ | 96.08 ± 6.83 | 97.17 ± 7.93 | 0.359 | 0.723 |
Comorbidities, n% | ||||
ADHD | 3, 25% | 1, 8.33% | ||
ODD | 1, 8.33% | 1, 8.33% | ||
OCD | 1, 8.33% | 0 | ||
Emotional disorder | 216.67% | 2, 16.67% | ||
Anxiety disorder | 5, 41.67% | 2, 16.67% | ||
Depressive disorder | 0 | 1, 8.33% |